Aceon and Gastrointestinal inflammation - a phase IV clinical study of FDA data

Summary:

Gastrointestinal inflammation is reported only by a few people who take Aceon.

The phase IV clinical study analyzes which people take Aceon and have Gastrointestinal inflammation. It is created by eHealthMe based on reports of 1,739 people who have side effects while taking Aceon from the FDA, and is updated regularly.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.

On Jun, 30, 2022

1,739 people reported to have side effects when taking Aceon.
Among them, 1 person (0.06%) has Gastrointestinal inflammation.

What is Aceon?

Aceon has active ingredients of perindopril erbumine. It is often used in high blood pressure. eHealthMe is studying from 1,780 Aceon users for its effectiveness, alternative drugs and more.

What is Gastrointestinal inflammation?

Gastrointestinal inflammation (inflammation of stomach and intestine) is found to be associated with 759 drugs and 492 conditions by eHealthMe.

Number of Aceon and Gastrointestinal inflammation reports submitted per year:

Could Aceon cause Gastrointestinal inflammation?

Time on Aceon when people have Gastrointestinal inflammation *:

Gender of people who have Gastrointestinal inflammation when taking Aceon *:

female: 100 %
male: 0.0 %

Age of people who have Gastrointestinal inflammation when taking Aceon *:

Common drugs people take besides Aceon *:

Coversyl Plus: 1 person, 100.00%

Common side effects people have besides Gastrointestinal inflammation *:

Crohn's Disease (condition that causes inflammation of the gastrointestinal tract): 1 person, 100.00%
Cough: 1 person, 100.00%
Colitis (inflammation of colon): 1 person, 100.00%

Common conditions people have *:

Birth Control: 1 person, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take Aceon and have Gastrointestinal inflammation?

Check whether Gastrointestinal inflammation is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Schwerd T, Pandey S, Yang HT, Bagola K, Jameson E, Jung J, Lachmann RH, Shah N, Patel SY, Booth C, Runz H, "Impaired antibacterial autophagy links granulomatous intestinal inflammation in Niemann–Pick disease type C1 and XIAP deficiency with NOD2 variants in Crohn9s disease", Gut, 2016 Mar .
Krishnan K, Krishnasamy K, "Evaluation of anaphylactic reaction as an adverse event for perindopril erbumine tablets", International Current Pharmaceutical Journal, 2014 Mar .

Related studies

Alternative drugs to, pros and cons of Aceon:

Aceon (1,780 reports)

Gastrointestinal inflammation treatments and more:

Gastrointestinal inflammation (6,885 reports)

COVID vaccines that are related to Gastrointestinal inflammation:

How severe was Gastrointestinal inflammation and when was it recovered:

Gastrointestinal inflammation in Aceon

Expand to all the drugs that have ingredients of perindopril erbumine:

Gastrointestinal inflammation and drugs with ingredients of perindopril erbumine (8 reports)

Common drugs associated with Gastrointestinal inflammation:

How the study uses the data?

The study uses data from the FDA. It is based on perindopril erbumine (the active ingredients of Aceon) and Aceon (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.